Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy

被引:5
|
作者
Siva, S. [1 ,2 ]
Senan, S. [3 ]
Ball, D. [1 ,2 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Radiat Oncol, East Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia
[3] Vrije Univ Amsterdam, Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
关键词
RADIOFREQUENCY ABLATION;
D O I
10.1093/annonc/mdv287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2196 / 2196
页数:1
相关论文
共 50 条
  • [21] ATLAS SEGMENTATION FOR LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY
    Barber, Jeffrey
    Sykes, Jonathan
    White, Sean
    Yeghiaian-Alvandi, Roland
    Hegi-Johnson, Fiona
    Unicomb, Kylie
    Small, Katherine
    Van Tilburg, Kevin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S847 - S847
  • [22] Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases A Review
    Glicksman, Rachel M.
    Tjong, Michael C.
    Neves-Junior, Wellington F. P.
    Spratt, Daniel E.
    Chua, Kevin L. M.
    Mansouri, Alireza
    Chua, Melvin L. K.
    Berlin, Alejandro
    Winter, Jeff D.
    Dahele, Max
    Slotman, Ben J.
    Bilsky, Mark
    Shultz, David B.
    Maldaun, Marcos
    Szerlip, Nicholas
    Lo, Simon S.
    Yamada, Yoshiya
    Vera-Badillo, Francisco Emilio
    Marta, Gustavo N.
    Moraes, Fabio Y.
    JAMA ONCOLOGY, 2020, 6 (04) : 567 - 577
  • [23] The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: Observations on efficacy and toxicity in clinical practice
    Nedzi, Lucien A.
    SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (04) : 265 - 272
  • [24] Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity
    Murray, Louise
    Karakaya, Ebru
    Hinsley, Samantha
    Naisbitt, Mitchell
    Lilley, John
    Snee, Michael
    Clarke, Katy
    Musunuru, Hima B.
    Ramasamy, Satiavani
    Turner, Rob
    Franks, Kevin
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1058):
  • [25] Investigating strategies to reduce toxicity in stereotactic ablative radiotherapy for central lung tumors
    Senthi, Sashendra
    Dahele, Max
    Slotman, Ben J.
    Senan, Suresh
    ACTA ONCOLOGICA, 2014, 53 (03) : 330 - 335
  • [26] Chest Wall Toxicity after Individualized Stereotactic Ablative Radiotherapy for Lung Tumors
    Lau, B.
    Wu, Y. F.
    Fu, J.
    Cui, S.
    Pham, D.
    Gee, H.
    Skinner, L.
    Shirato, H.
    Taguchi, H.
    Chin, A.
    Gensheimer, M.
    Diehn, M.
    Loo, B.
    Vitzthum, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S36 - S37
  • [27] Combination of stereotactic ablative body radiation with targeted therapies
    Zeng, Jing
    Baik, Christina
    Bhatia, Shailender
    Mayr, Nina
    Rengan, Ramesh
    LANCET ONCOLOGY, 2014, 15 (10): : E426 - E434
  • [28] Stereotactic ablative radiotherapy for early stage lung cancer and lung metastases in a New Zealand population
    Geary, Rebecca
    Yasin, Nur Azri Bin Haji Mohd
    Lin, Frank
    Whalley, Deborah
    Thotathil, Ziad
    DeGroot, Charles
    NEW ZEALAND MEDICAL JOURNAL, 2021, 134 (1529) : 45 - 56
  • [29] Stereotactic ablative body radiotherapy (SABR) for multiple lung tumours: hazardous or harmless?
    Allos, B.
    Carruthers, H.
    Harrop, V.
    Stange, D.
    Misheva, T.
    Stevenson, R.
    Watkins, S.
    Ghafoor, Q.
    LUNG CANCER, 2018, 115 : S58 - S58
  • [30] A strategy to reduce fraction number in peripheral lung stereotactic ablative body radiotherapy
    O'Keeffe, Serena
    Higgins, Martin J.
    Fleming, Cathy
    Armstrong, John
    Thirion, Pierre
    McClean, Brendan
    Vintro, Luis Leon
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 26